Table 1.
Non-PPM | PPM | p value | |
---|---|---|---|
N | 393 | 10 | |
Demographic data | |||
Age | 66 ± 10 years | 66 ± 16 years | > 0.9 |
Female | 110 (28%) | 6 (60%) | 0.04* |
Rheumatic heart disease | 4 (1%) | 2 (20%) | 0.008* |
Coronary artery disease | 211 (54%) | 5 (50%) | > 0.9 |
Hypertension | 223 (57%) | 5 (50%) | 0.75 |
Diabetes | 116 (30%) | 2 (20%) | 0.7 |
Hypercholesterolaemia | 112 (28%) | 0 (0%) | 0.07 |
PVD | 20 (5%) | 1 (10%) | 0.4 |
CKD | 36 (9%) | 3 (30%) | 0.06 |
COPD | 27 (7%) | 1 (10%) | 0.5 |
Pulmonary hypertension | 6 (2%) | 2 (20%) | 0.01* |
Preoperative heart rhythm | |||
Sinus rhythm | 334 (85%) | 8 (80%) | 0.7 |
AF | 56 (14%) | 2 (20%) | 0.6 |
Bundle branch blocks | 1 (0.3%) | 0 | > 0.9 |
1st degree AV block | 1 (0.3%) | 0 | > 0.9 |
VF/VT | 1 (0.3%) | 0 | > 0.9 |
Left ventricular ejection fraction (LVEF) | |||
Good > 50% | 319 (81%) | 8 (80%) | > 0.9 |
Moderate 31–50% | 61 (16%) | 2 (20%) | 0.65 |
Poor 21–30% | 10 (3%) | 0 (0%) | > 0.9 |
Very poor < 21% | 3 (1%) | 0 (0%) | > 0.9 |
NYHA class | |||
I | 62 (16%) | 0 (0%) | |
II | 226 (58%) | 5 (50%) | 0.2 |
III | 93 (24%) | 5 (50%) | |
IV | 12 (3%) | 0 (0%) |
PVD peripheral vascular disease, CKD chronic kidney disease, COPD chronic obstructive pulmonary disease, AF atrial fibrillation, VF/VT ventricular fibrillation/ventricular tachycardia, NYHA New York Heart Association